Mark JC Nuijten
A2M, Netherlands
Biography
Mark Nuijten trained as a Physician and worked in clinical practice before completing an international MBA from Erasmus University, Rotterdam. He completed his PhD in Health Economics at the Erasmus University, Rotterdam, in 2003 and the thesis entitled as “In search of more confidence in health economic modeling”. He was Board Director of ISPOR (2002-2004) and Chair of the Management Board of Value in Health (2002-2004). He is a pioneer in the field of Healthcare Innovation in Biotechnology and Nutrition, and has been the first classical health economist successfully applying and developing sales forecast methodologies for valuation of biotechnology companies. Prior to setting up A2M, he was a partner with MEDTAP International. As a VP Business Development for Europe, he established global Pricing and Reimbursement Consultancy Services for MEDTAP. Before MEDTAP, he was a Managing Director of the Quintiles office in the Netherlands
Abstract
Abstract : Early phase value scan for biotechnology innovation